Self-Reported Neuropsychiatric Post–COVID-19 Condition and CSF Markers of Neuroinflammation

Shelli F. Farhadian, MD, PhD1,2,3,4; Hailey D. Reisert, BS1; Lindsay McAlpine, MD3; et al, MA3,4 JAMA Netw Open. 2023;6(11):e2342741. doi:10.1001/jamanetworkopen.2023.42741 Introduction Long COVID, also known as post–COVID-19 condition (PCC), refers to a range of symptoms that may persist for weeks to months after acute COVID-19. A subset of people with PCC report neuropsychiatric symptoms (neuro-PCC); however, the mechanisms behind this phenomenon are not yet understood.1 Cerebrospinal […]

Neurological manifestations of post-acute sequelae of COVID-19: which liquid biomarker should we use?

Dominique Comeau1† Mykella Martin2† Gilles A. Robichaud3,4,5 Ludivine Chamard-Witkowski2,6*1Dr. Georges-L. Long COVID syndrome, also known as post-acute sequelae of COVID-19 (PASC), is characterized by persistent symptoms lasting 3–12 weeks post SARS-CoV-2 infection. Patients suffering from PASC can display a myriad of symptoms that greatly diminish quality of life, the most frequent being neuropsychiatric. Thus, there is an eminent need […]

Large COVID autopsy study finds SARS-CoV-2 all over the human body

By Rich Haridy January 04, 2023 Source: National Institute of Allergy and Infectious Diseases A study found traces of the SARS-CoV-2 virus in over 80 different sites in the body In the most comprehensive autopsy tissue study conducted to date, researchers have found traces of the SARS-CoV-2 virus throughout the entire body, from the brain and the […]